What a 2025 Scoping Review of 16 Clinical Trials Reveals About Hypnosis and Chronic Illness

Living with a chronic condition often means learning to manage symptoms that never fully disappear — persistent pain, exhaustion, anxiety, disrupted sleep. For millions of people, conventional treatment only goes so far. That's why a landmark 2025 scoping review, published in the International Journal of Clinical and Experimental Hypnosis, is attracting attention in medical circles: it systematically examined 16 randomised controlled trials (RCTs) and asked a straightforward question — can clinical hypnosis meaningfully help people with chronic illness?

The answer, across multiple conditions and outcomes, was a consistent yes.

What the Scoping Review Found

The review analysed 16 RCTs involving adults living with a range of chronic conditions, including fibromyalgia, cancer, obesity, and heart disease. Studies were predominantly conducted across Europe and the United States, giving the findings broad clinical relevance.

Across these trials, clinical hypnosis produced statistically meaningful improvements in five key areas:

• Pain reduction — participants reported lower pain intensity and greater ability to function
• Emotional distress — significant reductions in anxiety, low mood, and psychological burden
• Quality of life — improved scores on validated wellbeing measures
• Sleep quality — better sleep onset, duration, and restfulness
• Fatigue levels — notably for patients with fibromyalgia and cancer, where fatigue is often debilitating

The hypnosis interventions analysed typically incorporated relaxation induction, guided positive imagery, and self-hypnosis techniques — elements that participants could also practise independently between sessions. Several trials combined hypnosis with cognitive-behavioural therapy (CBT), suggesting an additive effect when the two approaches work together.

Why These Findings Matter

Chronic illness is one of the great unresolved challenges in modern healthcare. An estimated one in three UK adults lives with at least one long-term condition, and the conventional toolkit — medication, physiotherapy, talking therapies — frequently manages symptoms rather than addressing the relationship between mind, body, and pain perception.

What makes this review significant is its scope and methodology. RCTs are the gold standard of clinical research, designed to minimise bias. The fact that 16 independent trials, across different countries, patient populations, and chronic conditions, consistently pointed toward clinical hypnosis as a meaningful intervention — not merely a trend — is notable.

The findings align with what neuroscience increasingly tells us about hypnosis: it produces measurable changes in brain activity, particularly in areas that regulate attention, pain processing, and emotional response. When the mind is in a deeply relaxed, receptive state, the nervous system's response to pain signals and stress can be genuinely altered — not just masked.

For conditions like fibromyalgia and cancer, where fatigue and pain are both physiological and neurological in nature, this matters enormously. The review's authors highlight these two populations as showing particularly pronounced benefit, suggesting hypnosis may be especially well-suited to conditions where the mind-body connection is central to symptom experience.

The Self-Hypnosis Dimension

One of the most practically important aspects highlighted across the included trials was the role of self-hypnosis — the ability to independently practise the techniques learned through guided sessions. Unlike medications that require ongoing prescription, or therapy that requires a therapist present, self-hypnosis is a transferable skill.

For someone managing a chronic condition, this is significant. The ability to access a calming, pain-modulating mental state — whenever needed, as many times as needed — changes the equation from passive treatment to active self-management.

What This Means for You

If you're living with a chronic condition — whether that's persistent pain, fatigue, anxiety, or poor sleep — the evidence from this review suggests that hypnotherapy is worth serious consideration as a complementary approach alongside your existing care.

The key word is complementary. Hypnotherapy works best alongside, not instead of, medical treatment. But as this scoping review demonstrates, the evidence base is solid enough that it's no longer a fringe idea — it's a clinically examined tool with consistent, peer-reviewed results.

A Note on the Research

The 2025 scoping review's authors are careful to note methodological heterogeneity across the 16 trials — differences in session length, hypnotic technique, outcome measures, and patient populations make direct comparisons complex. More standardised, large-scale RCTs would strengthen the evidence further. This is a growing field, and the science continues to develop.

That said, 16 independent RCTs consistently pointing in the same direction is meaningful. For researchers, clinicians, and people living with chronic conditions alike, the signal is clear: clinical hypnosis deserves a place in the conversation.

Reference: Scoping review of randomised controlled trials on clinical hypnosis for chronic illnesses, International Journal of Clinical and Experimental Hypnosis, 2025. PubMed ID: 40706012.